Increasing PrEP Uptake in PWID
Season 5, Ep. 4
Take our post-test to claim CME credits.
To read a companion newsletter click here.
|People who inject drugs (PWID) are at risk for HIV infection from both sexual- as well as injection-related causes. What can clinicians do to reduce the incidence of infection and improve their patients’ health? In this issue, Dr. Jessica Taylor from The Boston University School of Medicine and Boston Medical Center takes us into the clinic to explain how current evidence-based strategies can increase the uptake of HIV pre-exposure prophylaxis in this vulnerable population.|
UPDATE 3/3/2021 - Herd Immunity Interview Part 1
Dr. Paul Auwaerter interviews Malia Jones, PhD, MPH about COVID-19 herd immunity. Topics: *Differences between herd immunity and transmission rate (Rt) *How vaccines accelerate herd immunity *Similarities in herd immunity between measles and COVID-19 *Communicating the importance of vaccine adoptionPost-test forCME/CE credit:https://covid19.dkbmed.com/multispecialty/3-3-21-episode/evalAccess our resource center, download webinar slides, and claim credit athttps://covid19.dkbmed.com/multispecialtyPresentingfaculty:Paul G. Auwaerter, MD, MBA, FIDSA,Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of MedicineMalia Jones, PhD, MPH,Assistant/Associate Scientist in Health Geography, Applied Population Laboratory, Department of Community and Environmental Sociology, University of Wisconsin-Madison
COVID-19 Epidemiology 101
Dr. Auwaerter describes our fundamental understanding of COVID-19 transmission, disease course, and potential routes for treatment.Topics: *SARS-CoV-2 pathogenesis *Viral variants: UK, Japan/Brazil, and South Africa *Where do infections occur? *Disease burden and risk factors *COVID-19 phases and interventionsPost-test for CME/CE credit:https://covid19.dkbmed.com/multispecialty/2-26-21-episode/evalAccess our resource center, download webinar slides, and claim credit athttps://covid19.dkbmed.com/multispecialtyPresenting faculty:Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine
UPDATE 2/17/21 - Frontline Treatments with Q&A
Drs. Paul Auwaerter and Charles Vega discuss the various COVID-19 treatment options and answer your questions. Topics: *Understanding treatment options for ambulatory and hospitalized patients *Accurately identifying patients eligible for monoclonal antibodies *Understanding when, how, and why various treatments work *Describing the safety and efficacy of various treatmentsPost-test for CME/CE credit:https://covid19.dkbmed.com/multispecialty/2-17-2021-frontline-treatments-with-q-a/evalAccess our resource center, download webinar slides, and claim credit athttps://covid19.dkbmed.com/multispecialtyPresenting faculty:Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA)andProfessor of Medicine at Johns Hopkins University School of MedicineCharles Vega, MD, FAAFP, Health Sciences Clinical Professor at UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education at UC Irvine School ofMedicine, andDirector, UC Irvine Program in Medical Education for the Latino Community